Paclitaxel/Carboplatin versus Carboplatin in Patients with Epithelial Ovarian Cancer and correlation to serum marker VEGF

Raafat Ragaie Abdel Malek;

Abstract


This study is a prospective non-randomized study including 50 patients with established diagnosis of epithelial ovarian carcinoma attending Kasr El Einy Centre of Clinical Oncology (NEMROCK) in the period from January 2006 to December 2007 inclusive.


Other data

Title Paclitaxel/Carboplatin versus Carboplatin in Patients with Epithelial Ovarian Cancer and correlation to serum marker VEGF
Other Titles مقارنة بين استخدام عقارى باكليتاكسيل مع كاربوبلاتين وعقار كاربوبلاتين بمفرده فى علاج حالات سرطان المبيض و علاقته بمستوى عامل نمو خلايا الأوعية الدموية بالدم
Authors Raafat Ragaie Abdel Malek
Keywords Paclitaxel/Carboplatin versus Carboplatin in Patients with Epithelial Ovarian Cancer and correlation to serum marker VEGF
Issue Date 20092009
Description 
This study is a prospective non-randomized study including 50 patients with established diagnosis of epithelial ovarian carcinoma attending Kasr El Einy Centre of Clinical Oncology (NEMROCK) in the period from January 2006 to December 2007 inclusive.

Attached Files

File SizeFormat
94026r1902.pdf197.32 kBAdobe PDFView/Open
Recommend this item

Similar Items from Core Recommender Database

Google ScholarTM

Check

views 8 in Shams Scholar
downloads 2 in Shams Scholar


Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.